Sensorion SA (ALSEN.PA) • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ALSEN.PA in your mock portfolio yet.
Sensorion SA is currently loss-making, as reflected in its negative EPS and PE ratio. The absence of positive earnings suggests the business is still in an investment or development phase, with profitability not yet in sight. This places greater dependence on future clinical, regulatory, or commercial milestones rather than current financial strength.
At €0.40, the stock trades modestly above its 200-day moving average of €0.36, and it has risen 5.9% over the last month. This suggests a slight positive momentum but not a strong breakout. Given the negative earnings backdrop, the current price action appears more like a mild recovery than a confirmed uptrend.
Alternative data for Sensorion SA is mixed: modest web traffic and relatively low social media following contrast with surprisingly high app download estimates. The lack of recent growth in Twitter/X followers points to limited incremental retail or public investor interest, while LinkedIn presence suggests some professional awareness. Overall, these signals do not yet indicate strong, broad-based commercial traction or investor enthusiasm.
Taken together, Sensorion SA’s negative earnings, lack of clear profitability trajectory, and only mildly positive technicals point to a bearish overall stance, despite a recent uptick in share price. Alternative data shows some encouraging signs in app activity but does not yet demonstrate strong, broad-based demand or investor momentum. The stock appears speculative and heavily dependent on future execution and catalysts rather than current fundamentals.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started